The results above delineate the alteration of SPTBN2 and BCL2L1 in view of tumor immune modulation mediated by CCL27 and CCR10, resulting in a reduced abundance of CD4+ T cells and dendritic cells. Here, BCL2L1 is linked to neoplasm.